MET and myeloid sarcoma: We next assessed c-Met expression on circulating CD4+ T cells from HDs, MS patients and MM patients by flow cytometry and observed similar results, with an increased CD4+c-Met+ T cell population in MS patients and an even greater extent in MM patients compared to that in HDs (Fig. 1K).